Activest Wealth Management’s AbbVie ABBV Stock Holding History

Activest Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.2K	Sell	100 -76	-43%	-$16.4K	﹤0.01%	396
2026 Q1	$38.3K	Sell	176 -148	-46%	-$32.8K	0.01%	385
2025 Q4	$74K	Sell	324 -106	-25%	-$24.1K	0.01%	257
2025 Q3	$99.6K	Buy	430 +93	+28%	+$18.9K	0.02%	185
2025 Q2	$62.6K	Buy	337 +15	+5%	+$2.79K	0.02%	184
2025 Q1	$67.5K	Buy	322 +312	+3,120%	+$60.7K	0.02%	164
2024 Q4	$1.78K	Buy	+10	New	+$1.84K	﹤0.01%	436
2024 Q3	–	Sell	-1,500	Closed	-$257K	–	575
2024 Q2	$257K	Buy	+1,500	New	+$248K	0.08%	71
2023 Q1	–	Sell	-228	Closed	-$36.8K	–	318
2022 Q4	$36.8K	Hold	228	–	–	0.01%	202
2022 Q3	$31K	Buy	+228	New	+$32.7K	0.01%	208
2021 Q4	–	Sell	-102	Closed	-$11K	–	322
2021 Q3	$11K	Buy	102 +1	+1%	+$114	0.01%	212
2021 Q2	$11K	Buy	101 +1	+1%	+$113	0.01%	187
2021 Q1	$11K	Buy	+100	New	+$10.7K	0.01%	179

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Activest Wealth Management's ABBV Position: Q2 2026 in Review

Activest Wealth Management reduced its AbbVie (ABBV) stake by 43% in Q2 2026, selling an estimated $16.4K and leaving 100 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

Activest Wealth Management first reported a position in ABBV in Q1 2021 and has held it in 13 quarters since. The position peaked at $257K in Q2 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Activest Wealth Management held 100 shares of AbbVie worth $25.2K as of Q2 2026.
Activest Wealth Management sold 76 AbbVie shares in Q2 2026, an estimated $16.4K.
AbbVie made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #396 holding.
Activest Wealth Management first reported a position in AbbVie in Q1 2021 and has held it in 13 quarters since.
Activest Wealth Management's AbbVie position peaked at $257K in Q2 2024.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.